NZD 2.25
(-0.44%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | 2.99 Million NZD | 52.36% |
2023 | 1.83 Million NZD | -18.08% |
2022 | 1.72 Million NZD | 0.96% |
2021 | 1.71 Million NZD | 8.62% |
2020 | 1.86 Million NZD | 16.94% |
2019 | 1.62 Million NZD | 62.65% |
2018 | 831.14 Thousand NZD | 140.54% |
2017 | 344.02 Thousand NZD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q3 | 934.66 Thousand NZD | -28.1% |
2024 Q4 | 934.66 Thousand NZD | 81.45% |
2024 FY | - NZD | 111.88% |
2024 Q2 | 1.3 Million NZD | 144.59% |
2024 Q1 | 531.5 Thousand NZD | -38.41% |
2023 Q4 | 1.09 Million NZD | 77.71% |
2023 Q2 | 695 Thousand NZD | 132.05% |
2023 FY | - NZD | -18.08% |
2023 Q1 | 299.5 Thousand NZD | -59.07% |
2023 Q3 | 616.74 Thousand NZD | -11.26% |
2022 Q4 | 731.71 Thousand NZD | 88.02% |
2022 Q3 | 389.17 Thousand NZD | -60.86% |
2022 Q2 | 994.29 Thousand NZD | 109.77% |
2022 Q1 | 474 Thousand NZD | -48.62% |
2022 FY | - NZD | 0.96% |
2021 Q1 | 500.26 Thousand NZD | -44.69% |
2021 FY | - NZD | 8.62% |
2021 Q4 | 922.52 Thousand NZD | 207.27% |
2021 Q3 | 300.23 Thousand NZD | -66.71% |
2021 Q2 | 901.83 Thousand NZD | 80.27% |
2020 Q4 | 904.43 Thousand NZD | 0.0% |
2020 Q2 | 669.52 Thousand NZD | 55.47% |
2020 FY | - NZD | 16.94% |
2020 Q1 | 430.64 Thousand NZD | 0.0% |
2019 FY | - NZD | 62.65% |
2018 FY | - NZD | 140.54% |
2017 FY | - NZD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Arvida Group Limited | 181.88 Million NZD | 98.353% |
Oceania Healthcare Limited | 53.36 Million NZD | 94.386% |
Radius Residential Care Limited | 29.17 Million NZD | 89.732% |
Ryman Healthcare Limited | -91.21 Million NZD | 103.285% |
Summerset Group Holdings Limited | 22.51 Million NZD | 86.696% |